Showing results (281-290 of 337) with videos related to

Sort By:
Pageof 34
Ethnicity & Health|July 29, 2015
Ethnic differences in types of social support from multiple sources after breast cancer surgeryDevika R Jutagir, Lisa M Gudenkauf, Jamie M Stagl, et al.
Urology|February 8, 2018
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy SpecimenCatherine M Dowling, Melissa Assel, John E Musser, et al.
Plos One|March 12, 2011
MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitorsNicola J Clegg, Suzana S Couto, John Wongvipat, et al.
Psychosomatic Medicine|May 24, 2003
Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virusDeidre Byrnes Pereira, Michael H Antoni, Aimee Danielson, et al.
Urology|August 11, 2024
Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell TumorsFady J Baky, Nicole Liso, Brandon Williams, et al.
Nature|February 13, 2009
ETS rearrangements and prostate cancer initiationBrett S Carver, Jennifer Tran, Zhenbang Chen, et al.
Psychological Medicine|March 7, 2012
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorderR Uher, S Carver, R A Power, et al.
Synapse (New York, N.Y.)|January 23, 2016
An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicityAshley N Fricks-Gleason, Christopher L German, Amanda J Hoonakker, et al.
Bio/Technology (Nature Publishing Company)|November 1, 1993
Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheepA S Carver, M A Dalrymple, G Wright, et al.
Investigational New Drugs|March 7, 2018
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancerLaura Graham, Kalyan Banda, Alba Torres, et al.
Pageof 34